Gossamer Bio Inc reports results for the quarter ended in June - Earnings Summary

Gossamer Bio

09/08/2022 14:56

* Gossamer Bio Inc  GOSS.OQ  reported a quarterly adjusted
loss
of 74 cents​​ per share for the quarter ended in June. The mean
expectation of nine analysts for the quarter was for a loss
of 70 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Gossamer Bio Inc's reported EPS for the quarter was a loss
of 74
cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Gossamer Bio Inc shares had risen by 55.6% this
quarter and
gained 15.1% so far this year.
    * The company reported a quarterly loss of $56.47 million.
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 01:56 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.70          -0.74          Missed
 Mar. 31 2022      -0.77          -0.76          Beat
 Dec. 31 2021      -0.74          -0.74          Met
 Sep. 30 2021      -0.78          -0.80          Missed